Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Shorting stocks: Broken stocks - Analysis -- Ignore unavailable to you. Want to Upgrade?

To: xcr600 who wrote (1932)	10/21/1998 3:21:00 AM
From: Q.	Read Replies (1) \| Respond to of 2506

Here's one I regret covering a month ago: HPRT just put out another discouraging news release. This really low RS stock is 3 3/4, right where I covered it, but it looks like it has a lot more room to the downside. It still has a $94 M market cap, which seems like a lot for a co. that loses $9 M per quarter on $3 M of revenues and has neg. shareholders equity. Their entire business consists of selling a patented heart-surgery method to doctors, and this has generated little success. Sort of reminds me of MCAR, but the medicine is less flakey. The latest earnings release says they have a new and improved version which they will phase into use over the next few quarters, which sounds pretty slow for generating business results.